| metanephric glomerular mesangium development | GO:0072223 | 3 | 1.000 | |
| urogenital system development | GO:0001655 | 261 | 1.000 | |
| kidney development | GO:0001822 | 213 | 1.000 | |
| vascular process in circulatory system | GO:0003018 | 62 | 1.000 | |
| mesonephric tubule development | GO:0072164 | 94 | 1.000 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 1.000 | |
| cardiocyte differentiation | GO:0035051 | 87 | 1.000 | |
| circulatory system process | GO:0003013 | 197 | 1.000 | |
| metanephric glomerular mesangial cell proliferation involved in metanephros development | GO:0072262 | 3 | 0.999 | |
| rhythmic process | GO:0048511 | 174 | 0.999 | |
| cardiac cell development | GO:0055006 | 41 | 0.999 | |
| positive regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway | GO:0035793 | 1 | 0.999 | |
| neuron projection guidance | GO:0097485 | 141 | 0.999 | |
| vasodilation | GO:0042311 | 28 | 0.999 | |
| ovarian follicle development | GO:0001541 | 40 | 0.999 | |
| superoxide metabolic process | GO:0006801 | 27 | 0.999 | Mouse |
| ureteric bud development | GO:0001657 | 94 | 0.999 | |
| response to peptide hormone | GO:0043434 | 127 | 0.998 | Rat |
| response to organonitrogen compound | GO:0010243 | 246 | 0.998 | Rat |
| positive regulation of apoptotic process involved in mammary gland involution | GO:0060058 | 4 | 0.998 | |
| response to oxygen levels | GO:0070482 | 62 | 0.998 | Mouse Rat |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.998 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.998 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.998 | |
| response to alcohol | GO:0097305 | 48 | 0.998 | Rat |
| cell migration involved in coronary angiogenesis | GO:0060981 | 1 | 0.998 | |
| glomerulus development | GO:0032835 | 40 | 0.998 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.997 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.997 | |
| heart trabecula formation | GO:0060347 | 14 | 0.997 | |
| embryonic hemopoiesis | GO:0035162 | 23 | 0.997 | |
| kidney epithelium development | GO:0072073 | 121 | 0.997 | |
| nephron development | GO:0072006 | 109 | 0.997 | |
| regulation of system process | GO:0044057 | 200 | 0.997 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.996 | |
| regulation of renal output by angiotensin | GO:0002019 | 2 | 0.996 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.996 | |
| regulation of tube size | GO:0035150 | 57 | 0.996 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.996 | |
| heart process | GO:0003015 | 94 | 0.996 | |
| regulation of peptidyl serine phosphorylation | GO:0033135 | 39 | 0.996 | |
| metanephric glomerular endothelium development | GO:0072264 | 1 | 0.995 | |
| bone development | GO:0060348 | 120 | 0.995 | Rat |
| metanephric mesenchymal cell migration | GO:0035789 | 2 | 0.995 | |
| muscle adaptation | GO:0043500 | 39 | 0.995 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.995 | |
| blood circulation | GO:0008015 | 195 | 0.995 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.995 | |
| negative regulation of systemic arterial blood pressure | GO:0003085 | 15 | 0.995 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.995 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.995 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.995 | |
| regulation of mesenchymal cell proliferation | GO:0010464 | 37 | 0.994 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.994 | |
| response to hypoxia | GO:0001666 | 58 | 0.994 | Mouse Rat |
| nephron epithelium development | GO:0072009 | 92 | 0.994 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.994 | |
| coronary vasculature development | GO:0060976 | 12 | 0.993 | |
| metanephric nephron development | GO:0072210 | 34 | 0.993 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.993 | |
| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 24 | 0.992 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.992 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.991 | |
| erythropoietin mediated signaling pathway | GO:0038162 | 1 | 0.991 | |
| axon guidance | GO:0007411 | 141 | 0.991 | |
| cell adhesion | GO:0007155 | 329 | 0.991 | |
| cellular response to erythropoietin | GO:0036018 | 1 | 0.991 | |
| brown fat cell differentiation | GO:0050873 | 36 | 0.991 | |
| positive regulation of smooth muscle cell migration | GO:0014911 | 4 | 0.990 | |
| axonogenesis | GO:0007409 | 274 | 0.990 | |
| cardiac vascular smooth muscle cell development | GO:0060948 | 3 | 0.990 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.990 | Mouse |
| regulation of metanephric mesenchymal cell migration | GO:2000589 | 2 | 0.989 | |
| regulation of dna templated transcription in response to stress | GO:0043620 | 9 | 0.989 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.989 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.987 | |
| regulation of cell migration | GO:0030334 | 219 | 0.987 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.987 | |
| angiogenesis | GO:0001525 | 201 | 0.987 | |
| blood vessel remodeling | GO:0001974 | 33 | 0.986 | |
| renal system development | GO:0072001 | 225 | 0.986 | |
| respiratory system development | GO:0060541 | 190 | 0.986 | |
| response to erythropoietin | GO:0036017 | 1 | 0.986 | |
| pro t cell differentiation | GO:0002572 | 3 | 0.985 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.985 | |
| lung vasculature development | GO:0060426 | 7 | 0.985 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.985 | |
| positive regulation of mesenchymal cell proliferation | GO:0002053 | 33 | 0.984 | |
| muscle tissue development | GO:0060537 | 308 | 0.984 | |
| regulation of the force of heart contraction | GO:0002026 | 17 | 0.983 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.983 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.983 | |
| response to peptide | GO:1901652 | 136 | 0.983 | Rat |
| regulation of cell activation | GO:0050865 | 289 | 0.983 | |
| vasoconstriction | GO:0042310 | 27 | 0.983 | |
| ovulation cycle | GO:0042698 | 59 | 0.981 | |
| positive regulation of metanephric mesenchymal cell migration | GO:2000591 | 1 | 0.981 | |
| cardiac muscle hypertrophy | GO:0003300 | 23 | 0.981 | |
| response to nutrient levels | GO:0031667 | 109 | 0.981 | |
| regulation of metanephros development | GO:0072215 | 15 | 0.980 | |
| organ growth | GO:0035265 | 117 | 0.980 | |
| amine metabolic process | GO:0009308 | 45 | 0.980 | |
| coronary vasculature morphogenesis | GO:0060977 | 9 | 0.979 | |
| metanephros morphogenesis | GO:0003338 | 24 | 0.979 | |
| regulation of smooth muscle cell migration | GO:0014910 | 6 | 0.979 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.978 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.978 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.978 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.978 | |
| positive regulation of kidney development | GO:0090184 | 28 | 0.977 | |
| cardiac endothelial cell differentiation | GO:0003348 | 4 | 0.977 | |
| cellular response to peptide | GO:1901653 | 92 | 0.977 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.977 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.976 | |
| intestinal absorption | GO:0050892 | 13 | 0.976 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.976 | |
| inositol lipid mediated signaling | GO:0048017 | 41 | 0.975 | |
| regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway | GO:1900238 | 1 | 0.974 | |
| metanephric mesangial cell differentiation | GO:0072209 | 1 | 0.974 | |
| positive regulation of bmp signaling pathway | GO:0030513 | 23 | 0.973 | |
| tissue migration | GO:0090130 | 68 | 0.973 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.973 | |
| positive regulation of growth | GO:0045927 | 104 | 0.972 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.972 | |
| maternal process involved in female pregnancy | GO:0060135 | 32 | 0.972 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.971 | Mouse |
| metanephric glomerulus development | GO:0072224 | 13 | 0.971 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.971 | |
| cardiac muscle fiber development | GO:0048739 | 4 | 0.970 | |
| positive regulation of retinal ganglion cell axon guidance | GO:1902336 | 2 | 0.970 | |
| regulation of nitrogen cycle metabolic process | GO:1903314 | 1 | 0.970 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.970 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.970 | |
| renal tubule development | GO:0061326 | 87 | 0.970 | |
| amide transport | GO:0042886 | 138 | 0.969 | |
| foramen ovale closure | GO:0035922 | 1 | 0.968 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.968 | |
| striated muscle hypertrophy | GO:0014897 | 24 | 0.968 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.967 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.967 | |
| lung development | GO:0030324 | 164 | 0.967 | |
| glomerular mesangial cell development | GO:0072144 | 3 | 0.967 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.966 | |
| positive regulation of phosphatidylinositol 3 kinase signaling | GO:0014068 | 20 | 0.966 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.965 | |
| positive regulation of axon extension | GO:0045773 | 20 | 0.965 | |
| gonad development | GO:0008406 | 141 | 0.964 | |
| cell proliferation involved in kidney development | GO:0072111 | 14 | 0.964 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.964 | |
| regulation of insulin receptor signaling pathway | GO:0046626 | 21 | 0.964 | |
| positive regulation of insulin receptor signaling pathway | GO:0046628 | 4 | 0.963 | |
| response to hyperoxia | GO:0055093 | 2 | 0.962 | Rat |
| intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1990127 | 1 | 0.962 | |
| angiogenesis involved in coronary vascular morphogenesis | GO:0060978 | 2 | 0.962 | |
| negative regulation of insulin secretion | GO:0046676 | 14 | 0.962 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.961 | |
| positive regulation of endothelial cell proliferation | GO:0001938 | 17 | 0.959 | |
| digestive tract development | GO:0048565 | 190 | 0.958 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.958 | Mouse Rat |
| regulation of fatty acid metabolic process | GO:0019217 | 28 | 0.958 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.958 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.958 | |
| cell migration involved in metanephros development | GO:0035788 | 2 | 0.958 | |
| female gamete generation | GO:0007292 | 74 | 0.957 | |
| platelet activation | GO:0030168 | 40 | 0.957 | |
| response to growth factor | GO:0070848 | 198 | 0.957 | Mouse Rat |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.956 | |
| camera type eye development | GO:0043010 | 266 | 0.955 | Rat |
| embryonic heart tube development | GO:0035050 | 65 | 0.954 | |
| embryonic heart tube morphogenesis | GO:0003143 | 51 | 0.954 | |
| cardiac right atrium morphogenesis | GO:0003213 | 3 | 0.953 | |
| female sex differentiation | GO:0046660 | 84 | 0.953 | |
| renal system process involved in regulation of systemic arterial blood pressure | GO:0003071 | 15 | 0.951 | |
| hormone secretion | GO:0046879 | 128 | 0.950 | |
| regulation of vasculogenesis | GO:2001212 | 9 | 0.950 | |
| muscle system process | GO:0003012 | 141 | 0.949 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.948 | |
| lactation | GO:0007595 | 25 | 0.947 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.947 | Rat |
| renal system process | GO:0003014 | 48 | 0.946 | |
| response to insulin | GO:0032868 | 100 | 0.946 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.945 | Mouse Rat |
| bone morphogenesis | GO:0060349 | 78 | 0.945 | |
| regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1902238 | 1 | 0.945 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.944 | |
| muscle contraction | GO:0006936 | 101 | 0.944 | Mouse |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.941 | |
| glomerular mesangial cell proliferation | GO:0072110 | 3 | 0.941 | |
| blood vessel endothelial cell migration | GO:0043534 | 23 | 0.941 | |
| glomerular epithelium development | GO:0072010 | 11 | 0.940 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.940 | Mouse |
| myeloid cell differentiation | GO:0030099 | 233 | 0.940 | |
| nephron tubule development | GO:0072080 | 84 | 0.939 | |
| negative regulation of smooth muscle cell apoptotic process | GO:0034392 | 1 | 0.938 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.936 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.935 | |
| metanephric glomerulus vasculature morphogenesis | GO:0072276 | 3 | 0.935 | |
| regulation of kidney development | GO:0090183 | 40 | 0.935 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.935 | |
| regulation of secretion | GO:0051046 | 274 | 0.934 | |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.934 | |
| mesonephros development | GO:0001823 | 97 | 0.934 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.934 | Rat |
| response to corticosteroid | GO:0031960 | 20 | 0.934 | Rat |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.933 | |
| endocardial cushion formation | GO:0003272 | 13 | 0.933 | |
| cation homeostasis | GO:0055080 | 212 | 0.932 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.931 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.928 | |
| positive regulation of branching involved in ureteric bud morphogenesis | GO:0090190 | 18 | 0.928 | |
| peptide secretion | GO:0002790 | 114 | 0.927 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.927 | Mouse |
| response to increased oxygen levels | GO:0036296 | 2 | 0.927 | Rat |
| cgmp biosynthetic process | GO:0006182 | 13 | 0.924 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.924 | |
| regulation of phosphatidylinositol 3 kinase signaling | GO:0014066 | 30 | 0.924 | |
| regulation of transcription from rna polymerase ii promoter in response to hypoxia | GO:0061418 | 2 | 0.921 | |
| dna metabolic process | GO:0006259 | 303 | 0.920 | |
| negative regulation of peptidyl serine phosphorylation | GO:0033137 | 10 | 0.919 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.919 | Mouse |
| platelet derived growth factor receptor signaling pathway | GO:0048008 | 32 | 0.919 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.918 | |
| mammary gland branching involved in pregnancy | GO:0060745 | 6 | 0.918 | |
| heart contraction | GO:0060047 | 93 | 0.918 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.917 | |
| phosphatidylinositol mediated signaling | GO:0048015 | 41 | 0.917 | |
| regulation of neuron death | GO:1901214 | 134 | 0.916 | |
| inflammatory response | GO:0006954 | 244 | 0.916 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.916 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.915 | |
| positive regulation of phosphoprotein phosphatase activity | GO:0032516 | 1 | 0.915 | |
| cartilage development | GO:0051216 | 140 | 0.915 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.914 | Rat |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.914 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.914 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.910 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.910 | |
| negative regulation of neurotrophin trk receptor signaling pathway | GO:0051387 | 2 | 0.910 | |
| calcium ion transport | GO:0006816 | 159 | 0.909 | |
| muscle cell development | GO:0055001 | 133 | 0.909 | |
| positive regulation of mitotic cell cycle embryonic | GO:0045977 | 2 | 0.909 | |
| sphingolipid metabolic process | GO:0006665 | 45 | 0.909 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.908 | |
| phosphatidylinositol 3 kinase signaling | GO:0014065 | 36 | 0.908 | |
| smooth muscle cell migration | GO:0014909 | 10 | 0.907 | |
| stem cell differentiation | GO:0048863 | 268 | 0.907 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.907 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.906 | |
| artery development | GO:0060840 | 53 | 0.906 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.904 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.903 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.903 | |
| spermatogenesis | GO:0007283 | 284 | 0.902 | |
| placenta development | GO:0001890 | 140 | 0.902 | |
| platelet derived growth factor receptor alpha signaling pathway | GO:0035790 | 3 | 0.902 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.902 | |
| vegf activated neuropilin signaling pathway | GO:0038190 | 2 | 0.901 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.901 | Mouse |
| rho protein signal transduction | GO:0007266 | 32 | 0.901 | |
| ventricular septum development | GO:0003281 | 42 | 0.900 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.900 | |
| positive regulation of cholesterol esterification | GO:0010873 | 1 | 0.897 | |
| microglia differentiation | GO:0014004 | 2 | 0.897 | |
| determination of heart left right asymmetry | GO:0061371 | 48 | 0.897 | |
| intestinal cholesterol absorption | GO:0030299 | 5 | 0.896 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.894 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.894 | |
| cell surface receptor signaling pathway involved in heart development | GO:0061311 | 15 | 0.889 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.888 | |
| response to retinoic acid | GO:0032526 | 56 | 0.888 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.888 | |
| regulation of blood vessel remodeling | GO:0060312 | 3 | 0.887 | |
| positive regulation of lipid kinase activity | GO:0090218 | 11 | 0.886 | |
| chemical homeostasis within a tissue | GO:0048875 | 9 | 0.886 | |
| septum primum development | GO:0003284 | 4 | 0.886 | |
| insulin receptor signaling pathway | GO:0008286 | 49 | 0.884 | |
| cell migration involved in kidney development | GO:0035787 | 3 | 0.884 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.884 | Mouse |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.883 | |
| stem cell maintenance | GO:0019827 | 130 | 0.883 | |
| renal system process involved in regulation of blood volume | GO:0001977 | 4 | 0.882 | |
| positive regulation of fatty acid oxidation | GO:0046321 | 4 | 0.881 | |
| response to thyroid hormone | GO:0097066 | 2 | 0.877 | |
| positive regulation of dephosphorylation | GO:0035306 | 6 | 0.877 | |
| positive regulation of insulin secretion | GO:0032024 | 26 | 0.877 | |
| connective tissue development | GO:0061448 | 179 | 0.877 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.876 | |
| coronary vein morphogenesis | GO:0003169 | 2 | 0.874 | |
| cell migration involved in vasculogenesis | GO:0035441 | 2 | 0.874 | |
| peptide transport | GO:0015833 | 133 | 0.873 | |
| cell migration involved in endocardial cushion formation | GO:0003273 | 3 | 0.870 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.870 | |
| positive regulation of lymphangiogenesis | GO:1901492 | 3 | 0.869 | |
| dna biosynthetic process | GO:0071897 | 22 | 0.869 | |
| retina vasculature development in camera type eye | GO:0061298 | 17 | 0.868 | |
| regulation of hematopoietic progenitor cell differentiation | GO:1901532 | 18 | 0.866 | |
| stem cell development | GO:0048864 | 219 | 0.866 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.864 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 73 | 0.864 | |
| cgmp metabolic process | GO:0046068 | 20 | 0.862 | |
| regulation of vasoconstriction | GO:0019229 | 14 | 0.861 | |
| regulation of cardiac muscle tissue development | GO:0055024 | 31 | 0.860 | |
| regulation of embryonic development | GO:0045995 | 71 | 0.860 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.859 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.859 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.855 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.855 | |
| cholesterol esterification | GO:0034435 | 3 | 0.854 | |
| regulation of triglyceride metabolic process | GO:0090207 | 17 | 0.854 | |
| germ cell development | GO:0007281 | 185 | 0.850 | |
| cellular response to x ray | GO:0071481 | 2 | 0.850 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.849 | |
| regulation of cell shape | GO:0008360 | 39 | 0.847 | |
| negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1902239 | 1 | 0.847 | |
| regulation of intrinsic apoptotic signaling pathway in response to osmotic stress | GO:1902218 | 1 | 0.845 | |
| positive regulation of fibroblast growth factor receptor signaling pathway | GO:0045743 | 3 | 0.845 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.844 | Rat |
| response to acid chemical | GO:0001101 | 111 | 0.844 | Rat |
| cardiac myofibril assembly | GO:0055003 | 12 | 0.844 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.843 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.843 | |
| catecholamine metabolic process | GO:0006584 | 30 | 0.840 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.839 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.839 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.838 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.837 | |
| smooth muscle contraction | GO:0006939 | 44 | 0.837 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.837 | |
| cholesterol storage | GO:0010878 | 4 | 0.835 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.833 | |
| positive regulation of mesonephros development | GO:0061213 | 20 | 0.833 | |
| digestion | GO:0007586 | 40 | 0.828 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.828 | Mouse |
| cell differentiation involved in kidney development | GO:0061005 | 33 | 0.827 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.826 | |
| eye photoreceptor cell differentiation | GO:0001754 | 41 | 0.826 | |
| embryonic placenta development | GO:0001892 | 98 | 0.825 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.825 | |
| positive regulation of hormone secretion | GO:0046887 | 38 | 0.825 | |
| negative regulation of epithelial cell migration | GO:0010633 | 9 | 0.824 | |
| steroid metabolic process | GO:0008202 | 119 | 0.824 | |
| negative regulation of endothelial cell proliferation | GO:0001937 | 8 | 0.824 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.822 | |
| metanephros development | GO:0001656 | 79 | 0.822 | |
| regulation of neurotrophin trk receptor signaling pathway | GO:0051386 | 4 | 0.821 | |
| fat cell differentiation | GO:0045444 | 160 | 0.820 | |
| wnt signaling pathway involved in kidney development | GO:0061289 | 2 | 0.819 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.817 | |
| atrial septum primum morphogenesis | GO:0003289 | 3 | 0.817 | |
| aorta morphogenesis | GO:0035909 | 22 | 0.817 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.815 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.814 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.813 | |
| metanephric tubule development | GO:0072170 | 18 | 0.812 | |
| positive regulation of nitric oxide synthase activity | GO:0051000 | 2 | 0.811 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.810 | |
| metanephric glomerular epithelium development | GO:0072244 | 3 | 0.810 | |
| positive regulation of nucleotide biosynthetic process | GO:0030810 | 26 | 0.809 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 43 | 0.809 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.808 | |
| response to monosaccharide | GO:0034284 | 67 | 0.807 | Rat |
| melanocyte adhesion | GO:0097326 | 1 | 0.806 | |
| cellular homeostasis | GO:0019725 | 240 | 0.806 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.804 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.803 | |
| respiratory tube development | GO:0030323 | 167 | 0.802 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.802 | |
| apoptotic process involved in mammary gland involution | GO:0060057 | 4 | 0.802 | |
| regulation of branching involved in ureteric bud morphogenesis | GO:0090189 | 22 | 0.801 | |
| regulation of glomerular filtration | GO:0003093 | 3 | 0.801 | |
| negative regulation of blood vessel endothelial cell migration | GO:0043537 | 3 | 0.800 | |
| collagen metabolic process | GO:0032963 | 17 | 0.800 | |
| male sex differentiation | GO:0046661 | 109 | 0.799 | |
| regulation of the force of heart contraction by chemical signal | GO:0003057 | 5 | 0.798 | |
| neuropilin signaling pathway | GO:0038189 | 2 | 0.798 | |
| regulation of intestinal cholesterol absorption | GO:0030300 | 4 | 0.797 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.797 | |
| platelet derived growth factor receptor beta signaling pathway | GO:0035791 | 4 | 0.797 | |
| metanephric glomerulus vasculature development | GO:0072239 | 7 | 0.794 | |
| phospholipase c activating angiotensin activated signaling pathway | GO:0086097 | 1 | 0.794 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.792 | Rat |
| heart valve development | GO:0003170 | 23 | 0.792 | |
| face development | GO:0060324 | 38 | 0.792 | |
| drug catabolic process | GO:0042737 | 2 | 0.790 | Mouse |
| phosphatidylinositol metabolic process | GO:0046488 | 45 | 0.789 | |
| digestive system development | GO:0055123 | 200 | 0.788 | |
| regulation of ion transport | GO:0043269 | 215 | 0.788 | |
| regulation of androgen receptor signaling pathway | GO:0060765 | 3 | 0.787 | |
| cellular response to amino acid stimulus | GO:0071230 | 29 | 0.786 | |
| face morphogenesis | GO:0060325 | 29 | 0.785 | |
| insulin secretion | GO:0030073 | 89 | 0.785 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.783 | |
| negative regulation of hormone secretion | GO:0046888 | 20 | 0.781 | |
| positive regulation of cgmp biosynthetic process | GO:0030828 | 6 | 0.781 | |
| regulation of wound healing | GO:0061041 | 40 | 0.781 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.780 | |
| mast cell differentiation | GO:0060374 | 5 | 0.780 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.780 | |
| ventricular cardiac muscle cell action potential | GO:0086005 | 4 | 0.779 | |
| cell growth involved in cardiac muscle cell development | GO:0061049 | 3 | 0.776 | |
| positive regulation of cardiac muscle tissue growth | GO:0055023 | 15 | 0.775 | |
| glomerular endothelium development | GO:0072011 | 2 | 0.774 | |
| t cell activation | GO:0042110 | 289 | 0.774 | |
| regulation of myeloid dendritic cell activation | GO:0030885 | 5 | 0.772 | |
| positive regulation of angiogenesis | GO:0045766 | 46 | 0.772 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.772 | |
| ossification | GO:0001503 | 216 | 0.771 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.771 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.770 | |
| regulation of axon extension | GO:0030516 | 43 | 0.769 | |
| positive regulation of vascular endothelial growth factor receptor signaling pathway | GO:0030949 | 5 | 0.769 | |
| antral ovarian follicle growth | GO:0001547 | 5 | 0.768 | |
| cell fate commitment | GO:0045165 | 210 | 0.764 | |
| pro b cell differentiation | GO:0002328 | 10 | 0.763 | |
| protein o linked glycosylation | GO:0006493 | 16 | 0.763 | |
| response to iron ion | GO:0010039 | 4 | 0.762 | |
| pigment cell differentiation | GO:0050931 | 27 | 0.760 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.758 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.757 | |
| negative regulation of endothelial cell migration | GO:0010596 | 4 | 0.756 | |
| regulation of cgmp metabolic process | GO:0030823 | 12 | 0.755 | |
| mesangial cell differentiation | GO:0072007 | 4 | 0.754 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.753 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.752 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.752 | |
| regulation of branching involved in salivary gland morphogenesis by epithelial mesenchymal signaling | GO:0060683 | 1 | 0.752 | |
| activation of janus kinase activity | GO:0042976 | 2 | 0.751 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.749 | |
| metanephric glomerulus morphogenesis | GO:0072275 | 3 | 0.748 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.748 | |
| response to vitamin d | GO:0033280 | 3 | 0.747 | |
| ventricular septum morphogenesis | GO:0060412 | 27 | 0.745 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.745 | |
| metanephric nephron morphogenesis | GO:0072273 | 19 | 0.744 | |
| maternal placenta development | GO:0001893 | 20 | 0.743 | |
| metanephric nephron epithelium development | GO:0072243 | 19 | 0.742 | |
| male gonad development | GO:0008584 | 88 | 0.741 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.740 | |
| cholesterol transport | GO:0030301 | 38 | 0.739 | |
| positive regulation of phosphatase activity | GO:0010922 | 4 | 0.739 | |
| g protein coupled receptor signaling pathway involved in heart process | GO:0086103 | 4 | 0.738 | Mouse |
| cellular response to thyroid hormone stimulus | GO:0097067 | 1 | 0.735 | |
| branching involved in mammary gland duct morphogenesis | GO:0060444 | 27 | 0.732 | |
| negative regulation of cartilage development | GO:0061037 | 17 | 0.732 | |
| g protein coupled receptor signaling pathway coupled to cgmp nucleotide second messenger | GO:0007199 | 1 | 0.731 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.729 | |
| kidney vasculature development | GO:0061440 | 15 | 0.728 | |
| positive regulation of myeloid cell differentiation | GO:0045639 | 43 | 0.728 | |
| epithelial cell differentiation involved in kidney development | GO:0035850 | 23 | 0.727 | |
| endothelial cell migration | GO:0043542 | 44 | 0.727 | |
| cellular response to oxygen levels | GO:0071453 | 20 | 0.727 | |
| endocardial cell differentiation | GO:0060956 | 4 | 0.726 | |
| positive regulation of fibroblast proliferation | GO:0048146 | 20 | 0.724 | |
| striated muscle contraction | GO:0006941 | 45 | 0.723 | Mouse |
| axon extension involved in axon guidance | GO:0048846 | 14 | 0.721 | |
| mitral valve morphogenesis | GO:0003183 | 4 | 0.721 | |
| mesenchymal cell proliferation | GO:0010463 | 44 | 0.721 | |
| macrophage differentiation | GO:0030225 | 20 | 0.720 | |
| outflow tract morphogenesis | GO:0003151 | 53 | 0.720 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.718 | |
| tertiary branching involved in mammary gland duct morphogenesis | GO:0060748 | 3 | 0.718 | |
| female gonad development | GO:0008585 | 71 | 0.717 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.715 | |
| positive regulation of behavior | GO:0048520 | 40 | 0.714 | |
| metanephric epithelium development | GO:0072207 | 21 | 0.714 | |
| fused antrum stage | GO:0048165 | 1 | 0.712 | |
| regulation of protein localization | GO:0032880 | 231 | 0.711 | |
| wound healing | GO:0042060 | 157 | 0.711 | |
| negative regulation of wnt signaling pathway involved in heart development | GO:0003308 | 4 | 0.710 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.710 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.709 | |
| positive regulation of cardiac muscle cell proliferation | GO:0060045 | 15 | 0.709 | |
| cardiac septum development | GO:0003279 | 59 | 0.709 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.708 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.706 | Rat |
| cardiac chamber development | GO:0003205 | 108 | 0.706 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.704 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.704 | |
| limb development | GO:0060173 | 166 | 0.704 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.703 | Rat |
| epithelial cell development | GO:0002064 | 159 | 0.703 | |
| growth plate cartilage development | GO:0003417 | 14 | 0.702 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.702 | |
| neural crest cell migration | GO:0001755 | 32 | 0.701 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.700 | |
| chondrocyte hypertrophy | GO:0003415 | 4 | 0.699 | |
| regulation of lymphangiogenesis | GO:1901490 | 3 | 0.698 | |
| male gamete generation | GO:0048232 | 285 | 0.695 | |
| cardioblast migration to the midline involved in heart field formation | GO:0060975 | 1 | 0.695 | |
| t cell differentiation | GO:0030217 | 174 | 0.695 | |
| positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090100 | 43 | 0.695 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.694 | |
